Study of of URC102 to Assess the Efficacy and Safety in Gout Patients
NCT04804111
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
171
Enrollment
INDUSTRY
Sponsor class
Conditions
Gout
Interventions
DRUG:
arm 0
DRUG:
arm 1
DRUG:
arm 2
DRUG:
arm 3
DRUG:
arm 4
Sponsor
JW Pharmaceutical